Triazine compounds as PI3 kinase and mTOR inhibitors

Details Triazine compounds as PI3 kinase and mTOR inhibitors Triazine compounds as PI3 kinase and mTOR inhibitors

2009-05-22

2011-10-18

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S113000

Reexamination Certificate

active

08039469

ABSTRACT:
Compounds of formula Iwherein:R1isand R2, R4, and R6-9are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.

REFERENCES:
patent: 1 020 462 (2000-07-01), None
patent: 1 020 462 (2004-02-01), None
Apr. 8, 2011 Non-Final Office Action issued in connection with U.S. Appl. No. 12/470,525.

Affiliated with

Also associated with

Rating

Triazine compounds as PI3 kinase and mTOR inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazine compounds as PI3 kinase and mTOR inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine compounds as PI3 kinase and mTOR inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4301837